Global Next Generation Sequencing Market Gains Traction in Post-Pandemic Era | $35.50 Billion by 2031

According to the report published by Allied Market Research, the global Next Generation Sequencing (NGS) Market was pegged at $6.59 billion in 2020 and is estimated to hit $35.50 billion by 2030, registering a CAGR of 18.2% from 2021 to 2030. The report provides an in-depth analysis of investment capital, winning strategies, drivers and opportunities, market size and strategy, competitive landscape and market dynamics.

The impact of the COVID-19 pandemic is expected to continue to be positive for the next generation sequencing industry. Because next-generation sequencing (NGS) diagnostic technology has the potential advantage of determining the genetic sequence of a virus and helping scientists understand the mutation of the virus. Additionally, genome sequencing has been used to understand the spread of Covid-19 and has the potential to understand the impact of interventions and help guide treatments in the future. For example, Covid-19 Genomics U.K. The consortium (COG-U.K.) Was formed in March 2020 to analyze the coronavirus genome using Whole Genome Sequencing (WGS. To combat the COVID-19 pandemic, researchers and scientists together identify the new corona virus strain without any prior knowledge.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.alliedmarketresearch.com/request-sample/2048

Key Benefits for Stakeholders -

• The report provides quantitative analysis of market segments, current trends, strategies and potential of next generation sequencing market research to identify potential next generation sequencing market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided. • Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global next generation sequencing market analysis, key players, market segments, application areas and Market growth strategies.

Major market players covered in the report -

Agilent Technologies, Inc
BGI Group
F. Hoffmann-La Roche AG
Illumina Inc
Precigen Inc., (Intrexon Bioinformatics Germany GmbH)
Pacific Biosciences of California, Inc
PerkinElmer, Inc.
PierianDx Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧:
https://www.alliedmarketresearch.com/request-for-customization/2048

According to analysts, the next generation sequencing market is expected to experience continuous growth in the future. The market has attracted interest from the healthcare industry. Due to the increase in various applications and interventions such as diagnostics, biomarker detection, personalized medicine. As a technology, NGS is better and higher than its predecessors, especially microarrays, due to the increased cost of the method based on the detailed genomic analysis. The next generation sequencing market is dominated by established players; therefore, the market is expected to be very competitive.

TABLE OF CONTENT -

CHAPTER 1 - INTRODUCTION:
1.1. Report description
1.2. Key market segments
1.3. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 - EXECUTIVE SUMMARY:
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3 - MARKET OVERVIEW:
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis/Top Player Positioning
3.4. Porter's Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities…
3.6. COVID-19 Impact Analysis on the market

Increased technological advances, especially nanopore sequencing in NGS, increased number of collaborations and partnerships to promote the use of NGS in hospitals and research centers, and increased genome mapping programs around the world. For example, in June 2021, Labcorp, a world leader in the life sciences industry, and OmniSeq, a molecular diagnostics company at the Rosewell Park Comprehensive Cancer Center, jointly announced the launch of OmniSeq INSIGHT, a next generation sequencing platform to advance precision oncology. and improve patient outcome. Additionally, in 2020, Quest Diagnostic, the largest clinical laboratory results database in the world, launched a next-generation automated sequencing engine to provide accurate genetic testing for inherited diseases.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/next-generation-sequencing-market/purchase-options

The next generation sequencing market is expected to witness a significant growth in the coming years. This market has gained interest of the healthcare and medical sectors owing to increased prevalence of hypertension throughout the globe. Furthermore, the global next generation sequencing market is segmented on the basis of product type, end user, and region. leading market players have been introducing various strategies to help enterprises move their on-premise models to on-demand models.

Frequently Asked Questions?

Q1. What is the total market value of next generation sequencing market report?

Q2. Which are the top companies holding the market share in next generation sequencing market?

Q3. Which are the largest regions for this Market?

Q4. What is the leading technology of next generation sequencing market?

Q5. What are the major drivers for this specific Market?

Q6. What are the upcoming key trends in the next generation sequencing market report?

𝗖𝗼𝗻𝘁𝗮𝗰𝘁:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.